A drug discovery platform leveraging the porosome, a cellular secretory portal, to target disease-causing proteins and develop treatments for various conditions including cancer, diabetes, and neurological disorders.

A treatment approach that reintroduces functional CFTR-associated porosome secretory complexes into lung epithelial cells to rectify deficiencies caused by non-functional mutated CFTR.